Wade Watson, Stage III Melanoma Survivor
A Diagnosis That Changed Everything In early 2021, Wade Watson and his father received life-changing news just weeks apart. His…
Blog - Melanoma360
03/26/2026
Wade Watson, Stage III Melanoma Survivor
A Diagnosis That Changed Everything In early 2021, Wade Watson and his father received life-changing news just weeks apart. His…
|
03/26/2026
Advocates Renew Call for RP1 Approval
As the U.S. Food and Drug Administration approaches a pivotal decision on a potential new treatment for advanced melanoma, patient…
|
03/03/2026
Cancer is More Than a Diagnosis: Mind, Meaning, and Healing
Cancer is often spoken about in terms of diagnosis, treatment plans, and survival rates. But there is a quieter, more…
|
02/19/2026
Merlin CP-GEP Becomes the First and Only Gene Expression Profile Test Recommended by NCCN®
San Diego, CA & Rotterdam, Netherlands- February 19, 2026 — SkylineDx today announced that the National Comprehensive Cancer Network® (NCCN®) has updated its…
|
|
02/05/2026
FDA Responds to Patient Advocacy on RP1 + Nivolumab
As part of our continued advocacy for patients with advanced melanoma, we are sharing the U.S. Food and Drug Administration’s…
|
02/05/2026
Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma
52% Amtagvi Response Rate with Two or Fewer Prior Lines of Therapy 73% Overall Disease Control Rate SAN CARLOS, Calif., Feb.…
|
|
01/23/2026
Moderna, Merck’s Skin Cancer Vaccine Shows Sustained Benefit in Five-Year Follow-Up
By Kamal Choudhury and Mariam E SunnyJanuary 20, 2026 3:52 PM EST Jan 20 (Reuters) – Moderna (MRNA.O), opens new tab and Merck…
|
01/21/2026
Reflecting on Melanoma Treatment in 2025 and Looking to the Future in 2026
The start of a new year is a time for reflection and looking to the future. This is an ideal…
|
01/13/2026
The Integrative Care Approach
Guest: Lisa Simms Booth, Executive Director, Smith Center for Healing and the Arts In this episode of the Beyond the…
|
01/13/2026
Improved Response to Immunotherapy with COVID-19 mRNA Vaccines
Introduction Data from a new study presented at the European Society for Medical Oncology (ESMO) meeting and published in Nature…
|
Recent Posts
May. 29, 2026
Replimune Announces Planned RP1 BLA Resubmission Following Productive Discussion with FDA
May. 26, 2026
The Importance of Self-Advocacy
May. 21, 2026
Webinar: Post-ASCO Melanoma Research Update
May. 04, 2026
Melanoma Monday: Every Day. Everywhere.
Apr. 27, 2026